The Cannabis Society: Berlin Medical Cannabis Conference
Markgrafenstraße 33, 10117 Berlin, Germany
Berlin, Germany
Berlin
Berlin
52.52000659999999
13.404953999999975
Description
The Cannabis Society is dedicated to fostering the cannabis community through events, conferences, dinners and much more.
Join us together with doctors from both Europe and North America, industry experts, investors and licensed producers in the cannabis business for our invite-only Medical Cannabis Conference.
With the goal to educate and form strategic partnerships, the Medical Conference is a unique way to interact with North American doctors, European doctors and the global cannabis industry.
The Cannabis Medical Conference is structured to include presentations from cannabis companies, followed by scheduled one-on-one meetings to be held between cannabis companies, North American doctors and European doctors (Meetings are scheduled in advance of the Conference). Attending and taking meetings with European doctors include
executives of the largest licensed producers and North American
doctors.
The schedule is as follows:
10:00 AM: Registration
10:30 AM: Opening remarks by The Cannabis Society
10:40 AM: Keynote by Peter Homberg, Partner, Denton
10:50 AM: Keynote by Tom Zuber, Managing Partner, Zuber Lawler
11:00 AM: Panel Discussion: The North American Landscape with North American Doctors11:30AM: Break
11:45 AM: Panel Discussion: The Current State of Cannabis
12:15 PM: Panel Discussion: Marketing Cannabis in Berlin
12:45 PM: Keynote by Dr. Constantin von der Groeben, Managing Director, DEMECAN
1:00 PM: Networking & Deal Making
CONFIRMED PARTICIPANTS:
Dr. Jonas Vanderzwan, MD, CCFP
Canadian physician with 15 years of primary care experience, and extensive experience in the use medical cannabis. As lead physician of a local cannabis clinic, he has been involved in the assessment and care of approximately 1500 patients, using cannabis as a treatment in a wide range of clinical conditions. As an early adopter of cannabis as a therapeutic agent, he has had the opportunity to travel the World, educating other medical professionals and patient groups on both the use and potential benefits of cannabis. Dr. Vanderzwan is an active consultant in the medical cannabis environment, having worked with both private and public players in the space, and since 2018 has been serving as Medical Director, and Chair of the Medical Advisory Board, for a Health Canada approved Licensed Producer of medical cannabis. In addition to ongoing membership in several international cannabinoid medicine organizations, Dr. Vanderzwan has most recently been appointed Vice-Chair of the Ontario Medical Association’s medical cannabis interest group.
Dr. Andrea Burry, MSc, MD, CCFP
Dr. Andrea Burry was the Medical Director of the Trauma Healing Center Cannabis Clinic since 2015. Dr. Burry completed her Bachelor of Science in Physiology and Psychology at the University of Western Ontario and both her Masters of Science and Medical Degree at the University of Toronto. She is a fellow of the Canadian College of Family Physicians and is an Associate with the Canadian Board of Occupational Medicine.Dr. Burry has an interest in medical cannabis and the role it can play in treating chronic pain and post-traumatic stress disorder. She is frequently called upon to speak or give an opinion on cannabis use in the workplace, particularly as it relates to safety sensitive roles. Dr. Burry currently divides her time between occupational medicine in both the public and private sector and clinical cannabis medicine and consulting.
Dr. Adam Norris, MD, DABFM, CCFP
Adam Norris has been working as a physician in Brantford, Ontario for the past 5 years.He completed his undergraduate studies at Dalhousie University in Neuroscience.Adam received his medical degree from Ross University and did a Family medicine residency at Northeastern University School of Medicine in Ohio. He is board certified in both Canada and the USA. Dr. Norris is a Family Physician and Medical Director of GreenDot Medical Center, Cannabinoid Clinic.He is currently Assistant Clinical Professor for Faculty of Family Medicine and Associate Professor at the MGD Centre for Medicinal Cannabis Research.This past year, he has taken a role as a consultant for Addiction Medicine at Brantford General Hospital.
Dr. Ranjit Bhardwaj, CannaPhytica
Academic and entrepreneur with a biomedical background, specialized in cellular and molecular Pathology. Major interest is Phytomedicine finding solutions for the chronic health conditions wherein Cannabis plants medicinal properties are also the central subject.
CannaPhytica has the overall objective to apply advanced biotechnical, agricultural methods to identify, analyse and protect indigenous strains of cannabis in Himalaya region to support the cannabis industries. The project includes collecting samples of strains, various kinds of scientific analysis, cataloguing and plant tissue preservation as cooperarive intellectual property of the region and CannaPhytica framed as a charitable foundation.
Besides preserving the biodivercity genetics it ensures the availability of these strains for medical research and development. The further steps of this work are to identify and develop disease-specific cannabis strains and secure these as intellectual property. This project is being elaborated in a cooperation to generate single cannabis molecules as pharmaceuticals by applying molecular biology techniques.
Tom Zuber, Managing Partner of Zuber Lawler
Tom Zuber has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. Tom holds a law degree from Columbia Law School, a master’s degree in public policy from Harvard Government School, and a biomedical engineering degree from Rutgers University, where he graduated with highest honors.
Joris Elstgeest, Owner, Elstgeest Potplants
Joris took over the family company Elstgeest Potplants in 2010 and was able to drive and develop the business to the healthy state as it is today. His study background is Agronomy and he has a Master of Science in Management degree at the Van Hall Institute in Leeuwarden, linked to the University of Greenwich in London. Since 2014 he has been participating in several consortia working on scientific research with ingredients and the biological cultivation of all kind of crops. The most advanced project was seemed to be the Vanilla project. Furthermore Joris is co-owner and Managing Director of a farm of 1800 hectares in Uganda where he grows mainly Stevia and Moringa for the European market.
Emanuel Kotzian, CEO Agentur Sowjet GmbH
For more than twenty years Emanuel Kotzian dedicates himself to the education about the effects of marihuana and lobbies for the re-normalization of this classic cultural plant. In 2000 he established Germany's biggest Cannabis-Magazine “Hanf Journal” and founded Agentur Sowjet GmbH, where he currently serves successful as its CEO. With more than 1 million fans, followers and readers on several channels, Agentur Sowjet is one of the leading marketing companies on the European Hemp Market. Its network of companies and branch offices extends from the Canary Islands to Kiev in the Ukraine and represents a unique platform for any market participant. Emanuel Kotzian was born 1972 in Krakow and immigrated with his family to Germany where he became a professing World-Citizen. After finishing High School in 1992 he studied Economics. Partly he was serving at a German court as a commercial judge, what did not stop him to get engaged into local politics. Now he is deeply involved in the promotion and up rise of CBD-Products, what he believes is a very important key for making hemp a normal and accepted natural product again."
Sandrina Koemm-Benson, Editor-in-Chief, Leafly.de
Sandrina Koemm-Benson is the editor-in-chief of Leafly.de since the launch in May 2017. The 45-year-old trained editor with a bachelor's degree in marketing has a very close personal connection to the subject of medical cannabis. Therefore, after nearly 20 years working in the media and PR business, she dropped her own agency and joined Leafly.de. Since the launch of Leafly.de in May 2017, she has been an advocate for patients and a recognized contact for physicians and industry representatives. She has built up an extensive international network in all directions and has a lot of insider knowledge. Under her editorial guidance, Leafly.de has become the leading knowledge portal on cannabis as a medicine in the German-speaking European countries. With more than 300,000 visitors per month, the independent online portal is the number one source of information for physicians, patients and healthcare professionals. As an expert, she is often on the road to educate and inform people about the topic. Leafly.de is the German representation of Leafly.com which is considered to be the largest cannabis knowledge base worldwide.
Dr. Constantin von der Groeben, Managing Director, DEMECAN
Dr. Constantin von der Groeben is a co-founder and managing director of DEMECAN, and leads the company’s legal and regulatory affairs department. Under his direction, DEMECAN’s Joint Venture with Canadian LP Wayland won Germany’s tender process on cannabis cultivation licenses. Dr. vonder Groeben’s expertise lies in the regulatory framework of medicinal cannabis including EU-GMP, narcotics, and pharmaceutical law. He believes that smart regulation of medicinal cannabis will allow for the development of a genuine pharmaceutical product that will be widely accepted by doctors, patients, and society as a whole.
Peter Homberg, Partner, Dentons
Peter Homberg is a partner in the Dentons Berlin office. He focuses on life sciences, IP, corporate law and M&A transactions in the life sciences and high-tech sector as well as in R&D and cooperation agreements, cross-border IP licensing and IP strategies. Furthermore, he has extensive experience providing legal advice on compliance issues. Additionally, he is the head of the European Cannabis sector group. Peter advises inter alia companies in the pharmaceutical, diagnostics, biotechnology, medical device and medical cannabis industries—from startups to large publicly listed companies. Furthermore, he has broad transactional experience in Southeast Asia. Peter is member of the Licensing Executive Society (LES), the German Association for Intellectual Property and Copyright (GRUR), the German Institution for Arbitration (DIS) as well as the Pharma-Lizenz-Club Deutschland e.V. He regularly holds lectures at seminars and conferences. He is the author of numerous professional articles and other publications regarding corporate or IP law in the field of life sciences.
Boris Moshkovits, Co-founder and Managing Director, alephSana
Boris Moshkovits is a Cannapreneur and experienced founder with a demonstrated history of working in the media, pharma and internet industry. He is the co-founder and managing director of alephSana, a company focused on scouting for qualified medical cannabis products globally and on bringing the best cannabis therapeutics to Germany and Europe. Moshkovits has served as International digital marketing manager in the pharma industry walking the fine line of marketing and digital storytelling in highly regulated markets. As a speaker Moshkovits has been talking about the mainstreaming of medical cannabis and the future of cannabis as a lifestyle product. He is also the co-founder of the CannaBusinessClub.Berlin, an initiative to empower the local cannabis scene. In his publishing career, he was the head of digital media for Ringier Publishing Germany and publisher of Amuse for Vice Media Germany. Prior to this, he has worked as an editor and publisher in Milan, Moscow and New York.
Gold Partners:
This listing has no upcoming events
Start:
2019-06-21T10:00:00+02:00
End:
2019-06-21T13:00:00+02:00
Category
Business
Tickets
General Admission (Early Bird)
49.0
EUR
15
General Admission
99.0
EUR
40